首页> 外国专利> A Chimeric Nucleic Acid Molecule to induce Self regulated apoptosis in inflammatory cells, a process for their PreparationUnacomposicion Pharmaceuticals containing such a Molecule, and a method for treating an inflammatory disorder using such compositions, and Methods

A Chimeric Nucleic Acid Molecule to induce Self regulated apoptosis in inflammatory cells, a process for their PreparationUnacomposicion Pharmaceuticals containing such a Molecule, and a method for treating an inflammatory disorder using such compositions, and Methods

机译:在炎症细胞中诱导自我调节细胞凋亡的嵌合核酸分子,其制备方法,包含该分子的合成药物以及使用该组合物治疗炎性疾病的方法和方法

摘要

A chimeric acid molecule comprising: at least one TNFalfa promoter booster region linked to a TNFalfa promoter, the booster region comprising SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 11, SEQ ID NO: 12 nucleic acid or a conservative substitution or allelic variants thereof; the TNF alpha promoter is also attached or a nucleic acid sequence encoding the Granzyme B protein or a conservative substitution or allelic variants thereof, which, in turn,They are related to a series of 3utr nucleic acids A drug synthesis method containing the above-mentioned chemical nucleic acid molecules, a method for treating a combustible disorder, which can be understood by a patient who needs such treatmentComment more than a month ago A process for manufacturing chemical nucleic acid molecules, including at least one tnfalf initiator enhancer, plus a functional copy of the smallest tnfalf regulator, plus at least one copy of the moldy induced nucleic acid moleculesfunctionIn addition, there is a nucleic acid sequence tnfalfa-3utr. In this sequence, the expression of the nucleic acid leading to aputosis is driven by the initiator of tnfal. The program includes: (a) expanding a nucleic acid molecule through chain reaction, including a tnfafa initiator a. (b) clone the nucleic acid amplified by polychlorinated biphenyls (a series of nuclear information acids above A9) to produce a building;(c) Test the composition and inductive performance of at least one tnfalf production line obtained in paragraph (b); and
机译:一种嵌合分子,其包含:至少一个与TNFalfa启动子连接的TNFalfa启动子增强区,所述增强区包含SEQ ID NO:4,SEQ ID NO:5,SEQ ID NO:11,SEQ ID NO:12核酸或保守取代或其等位变体;还连接了TNFα启动子或编码Granzyme B蛋白或其保守取代或等位基因变体的核酸序列,它们又与一系列3utr核酸有关。一种含有上述提及的药物合成方法化学核酸分子,一种可燃性疾病的治疗方法,需要这种治疗的患者可以理解。一个多月前的评论一种制造化学核酸分子的方法,包括至少一种tnfalf引发剂增强剂以及功能性复制品最小的tnfalf调节剂,加上至少一个霉菌诱导的核酸分子功能拷贝。此外,还有一个核酸序列tnfalfa-3utr。在该序列中,导致恶臭的核酸的表达由tnfal的启动子驱动。该程序包括:(a)通过链反应扩增核酸分子,包括tnfafa引发剂a。 (b)克隆多氯联苯(A9以上的一系列核信息酸)扩增的核酸以产生建筑物;(c)测试至少一条(b)所得的tnfalf生产线的组成和诱导性能;和

著录项

  • 公开/公告号AR014661A1

    专利类型

  • 公开/公告日2001-03-28

    原文格式PDF

  • 申请/专利权人 BOEHRINGER INGELHEIM PHARMACEUTICALS INC.;

    申请/专利号AR1999P100832

  • 发明设计人

    申请日1999-02-26

  • 分类号C12N15/85;C12N9/64;C12N5/10;C12Q1/68;A61K31/70;A61K48/00;

  • 国家 AR

  • 入库时间 2022-08-22 01:26:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号